 |
Ann Arbor, Mich. (February 13, 2007) — Compendia Bioscience, Inc. today announced results of a productive first year, including the formation of an experienced entrepreneurial management team, acquisition of its first 10 customers — including 8 of the top 20 oncology drug companies — and the completion of funding agreements providing capital for accelerated growth.
Under the leadership of CEO John Freshley, Compendia Bioscience has assembled a diverse management team with decades of experience in leading life science and software industry companies such as Spotfire, Gene Logic, Celera, and I3 Statprobe. Mr. Freshley was previously President and CEO of Ann Arbor-based Genetics Squared and remains on its Board of Directors.
“Compendia Bioscience was formed to commercialize Oncomine, a leading web application serving more than 10,000 users within the academic oncology research community,” said Mr. Freshley. “We have been very fortunate to identify a management group that is so well qualified to transition Oncomine into a resource as powerful for the commercial sector as it has been for the academic sector.”
Launched with seed funds from Ann Arbor Spark!, Compendia also won funding in the first round of the 21st Century Jobs Fund from the State of Michigan, along with matching funds provided by private investors. Additionally, the company has received early revenue by closing licensing agreements with its first 10 customers, including many leading oncology research organizations.
Compendia Bioscience is dedicated to harnessing the global collection of high throughput molecular data to provide researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, and optimize clinical studies. Compendia’s first product, Oncomine™ Professional, empowers oncology research by bringing advanced data analysis tools to the world’s largest cancer gene expression database, which now includes data from 18,740 microarray experiments curated from 264 independent studies. Oncomine was originally developed for academic use at the University of Michigan, and continues to be freely available to academic users. Compendia Bioscience was founded in 2006 to extend Oncomine to the commercial sector, and is headquartered in Ann Arbor, Michigan.
For additional information regarding this announcement, please contact:
John Freshley
Chief Executive Officer
Phone: (734) 330-2259
 media@compendiabio.com
|
|
